Endo International plc - Ordinary Shares (ENDP): Price and Financial Metrics


Endo International plc - Ordinary Shares (ENDP)

Today's Latest Price: $3.18 USD

0.09 (2.91%)

Updated Apr 3 12:00am

Add ENDP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ENDP Stock Summary

  • Endo International plc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 3.43% of US listed stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -14.96 for Endo International plc; that's greater than it is for merely 1.45% of US stocks.
  • Over the past twelve months, ENDP has reported earnings growth of -127.07%, putting it ahead of only 11.62% of US stocks in our set.
  • Stocks that are quantitatively similar to ENDP, based on their financial statements, market capitalization, and price volatility, are SGMS, ENT, VVUS, SIX, and INAP.
  • ENDP's SEC filings can be seen here. And to visit Endo International plc's official web site, go to www.endo.com.
ENDP Daily Price Range
ENDP 52-Week Price Range

ENDP Stock Price Chart More Charts


ENDP Price/Volume Stats

Current price $3.18 52-week high $8.55
Prev. close $3.09 52-week low $1.97
Day low $3.01 Volume 3,330,100
Day high $3.25 Avg. volume 7,075,272
50-day MA $4.88 Dividend yield N/A
200-day MA $4.21 Market Cap 721.33M

Endo International plc - Ordinary Shares (ENDP) Company Bio


Endo International plc focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The company was founded in 1920 and is based in Dublin, Ireland.

ENDP Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$3.18$0.39-87%

We started the process of determining a valid price forecast for Endo International plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Endo International plc ranked in the 11th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 87.17%. As for the metrics that stood out in our discounted cash flow analysis of Endo International plc, consider:

  • 8% of the company's capital comes from equity, which is greater than just 4.14% of stocks in our cash flow based forecasting set.
  • Endo International plc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at 0.24. This coverage rate is greater than that of just 19.48% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • The weighted average cost of capital for the company is 17. This value is greater than 98.58% stocks in the Healthcare sector that generate free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-88%
1%-87%
2%-87%
3%-87%
4%-87%
5%-87%

CPIX, CPHI, CMD, OSMT, and CRY can be thought of as valuation peers to ENDP, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


ENDP Latest News Stream


Event/TimeNews Detail
Loading, please wait...

ENDP Latest Social Stream


Loading social stream, please wait...

View Full ENDP Social Stream

ENDP Price Returns

1-mo -36.27%
3-mo -32.12%
6-mo -19.49%
1-year -61.22%
3-year -70.93%
5-year -96.47%
YTD -32.20%
2019 -35.75%
2018 -5.81%
2017 -52.94%
2016 -73.10%
2015 -15.11%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7856 seconds.